The dopamine D2/D3 receptor antagonist APD421 in combination with ondansetron effectively prevents acute cisplatin-induced nausea and vomiting (CINV)

Jørn Herrstedt, Y. Summers, Gedske Daugaard, T. B. Christensen, Karin Holmskov, P. D. Taylor, Gabriel Fox

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato2012
StatusUdgivet - 2012
Begivenhed37th European Society of Medical Oncology - Wien, Østrig
Varighed: 28. sep. 20122. okt. 2012
Konferencens nummer: 37

Konference

Konference37th European Society of Medical Oncology
Nummer37
LandØstrig
ByWien
Periode28/09/201202/10/2012

Citer dette

Herrstedt, J., Summers, Y., Daugaard, G., Christensen, T. B., Holmskov, K., Taylor, P. D., & Fox, G. (2012). The dopamine D2/D3 receptor antagonist APD421 in combination with ondansetron effectively prevents acute cisplatin-induced nausea and vomiting (CINV). Poster session præsenteret på 37th European Society of Medical Oncology, Wien, Østrig.
Herrstedt, Jørn ; Summers, Y. ; Daugaard, Gedske ; Christensen, T. B. ; Holmskov, Karin ; Taylor, P. D. ; Fox, Gabriel. / The dopamine D2/D3 receptor antagonist APD421 in combination with ondansetron effectively prevents acute cisplatin-induced nausea and vomiting (CINV). Poster session præsenteret på 37th European Society of Medical Oncology, Wien, Østrig.
@conference{802a26ecc3af4e87a784d11a8aaf76ce,
title = "The dopamine D2/D3 receptor antagonist APD421 in combination with ondansetron effectively prevents acute cisplatin-induced nausea and vomiting (CINV)",
author = "J{\o}rn Herrstedt and Y. Summers and Gedske Daugaard and Christensen, {T. B.} and Karin Holmskov and Taylor, {P. D.} and Gabriel Fox",
year = "2012",
language = "English",
note = "null ; Conference date: 28-09-2012 Through 02-10-2012",

}

Herrstedt, J, Summers, Y, Daugaard, G, Christensen, TB, Holmskov, K, Taylor, PD & Fox, G 2012, 'The dopamine D2/D3 receptor antagonist APD421 in combination with ondansetron effectively prevents acute cisplatin-induced nausea and vomiting (CINV)', 37th European Society of Medical Oncology, Wien, Østrig, 28/09/2012 - 02/10/2012.

The dopamine D2/D3 receptor antagonist APD421 in combination with ondansetron effectively prevents acute cisplatin-induced nausea and vomiting (CINV). / Herrstedt, Jørn; Summers, Y.; Daugaard, Gedske; Christensen, T. B. ; Holmskov, Karin; Taylor, P. D.; Fox, Gabriel.

2012. Poster session præsenteret på 37th European Society of Medical Oncology, Wien, Østrig.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

TY - CONF

T1 - The dopamine D2/D3 receptor antagonist APD421 in combination with ondansetron effectively prevents acute cisplatin-induced nausea and vomiting (CINV)

AU - Herrstedt, Jørn

AU - Summers, Y.

AU - Daugaard, Gedske

AU - Christensen, T. B.

AU - Holmskov, Karin

AU - Taylor, P. D.

AU - Fox, Gabriel

PY - 2012

Y1 - 2012

M3 - Poster

ER -

Herrstedt J, Summers Y, Daugaard G, Christensen TB, Holmskov K, Taylor PD et al. The dopamine D2/D3 receptor antagonist APD421 in combination with ondansetron effectively prevents acute cisplatin-induced nausea and vomiting (CINV). 2012. Poster session præsenteret på 37th European Society of Medical Oncology, Wien, Østrig.